CET - Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its results for the year ending 31 December ...

The president and his administration have waged a corrupt, chaotic, and cruel assault on the United States and its people ...

That being said, we’re here with a list of the 30 stocks that should double in 3 years.

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Monogram Technologies (NASDAQ:MGRM) is an AI-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution ...

Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare ...

Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing ...

The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...

Telix Pharmaceuticals has been shocked by the US Food & Drug Administration's rejection of marketing approval for its brain ...

Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...

Republican Sen. Bill Cassidy, a Louisiana doctor, released a report Thursday detailing "much-needed" reforms to the drug pricing program. Also: A House Democrat demands to know how the CDC will ...

Additionally, Ajit Singh, M.S., Ph.D., will join Harbinger's Board of Directors. Dr. Singh is a partner at Artiman Ventures with extensive expertise leading and advising healthcare organizations ...